Unlock stock picks and a broker-level newsfeed that powers Wall Street.
294.05
-17.65
(-5.66%)
At close: April 7 at 3:29:25 PM GMT+5:30
Key Executives
Amounts are as of December 31, 2024 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in INR.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Pawan Chaudhary | Chairman, MD & CFO | 12.77M | -- | 1964 |
| Mr. Ashutosh Jain B.A., LL.B | CEO, Head of Legal, Regulatory Dept. & Whole-Time Director | 7.15M | -- | 1977 |
| Dr. Manu Chaudhary | Joint MD, Head of Research, Development & Operations and Whole-Time Director | 12.53M | -- | 1969 |
| Mr. Akshansh Chaudhary | CTO & Executive Time Director | 5.19M | -- | 1993 |
| Mr. Peeyush Jain | Deputy MD, Head of Indian Marketing Operations & Whole-Time Director | 7.69M | -- | 1971 |
| Mr. Jitendra Singh | Chief General Manager of Administration | -- | -- | -- |
| Ms. Neha Kodan | Company Secretary & Compliance Officer | -- | -- | -- |
| Mr. Ajeet Kapoor | VP & Head of CAAR Division | -- | -- | -- |
| Mr. Manav Soni | President of Plant & Commercial | -- | -- | -- |
| Mr. Rakesh Pandita | Chief General Manager of Secretarial & Banking | -- | -- | -- |
Venus Remedies Limited
Plot 51-52, Industrial Area
Phase-1
Panchkula, 134113
India
- Sector:
- Healthcare
- Industry: Drug Manufacturers - Specialty & Generic
- Full Time Employees:
- 1,187
Description
Venus Remedies Limited engages in the pharmaceutical business in India and internationally. The company offers its products in various therapeutic areas, such as analgesic, analgesic and antipyretic, anti-diabetic, antibiotic, antiemetic, antiviral, cardiovascular, disinfectant and antiseptic, gastro therapy, hepatoprotective, hormones, immunostimulating agent, iron supplements, muscle relaxant, neurology, oncology, solvent, respiratory, and anticoagulant. It is also involved in the provision of portfolio of herbal products. Venus Remedies Limited was incorporated in 1989 and is headquartered in Panchkula, India.
Corporate Governance
Venus Remedies Limited’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
February 4, 2025 at 10:59 AM UTC
Venus Remedies Limited Earnings Date
Recent Events
September 23, 2013 at 12:00 AM UTC
Ex-Dividend Date
Related Tickers
JAGSNPHARM.NS Jagsonpal Pharmaceuticals Limited
202.88
-6.00%
GUFICBIO.NS Gufic Biosciences Limited
310.05
-5.59%
KILITCH.NS Kilitch Drugs (India) Limited
341.05
+1.26%
INDSWFTLTD.NS Ind-Swift Limited
13.00
-3.99%
MANGALAM.NS Mangalam Drugs & Organics Limited
73.32
-6.34%
SAKAR.NS Sakar Healthcare Limited
236.04
-2.56%
MEDICAMEQ.NS Medicamen Biotech Limited
458.15
-8.44%
APLLTD.NS Alembic Pharmaceuticals Limited
844.95
-4.12%
ALPA.NS Alpa Laboratories Limited
103.34
-5.09%
ERIS.NS Eris Lifesciences Limited
1,274.65
-3.53%